Immunic
IMUX
IMUX
45 hedge funds and large institutions have $51.7M invested in Immunic in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
93% less call options, than puts
Call options by funds: $8K | Put options by funds: $115K
Holders
45
Holding in Top 10
–
Calls
$8K
Puts
$115K
Top Buyers
| 1 | +$901K | |
| 2 | +$666K | |
| 3 | +$275K | |
| 4 |
DY
Dowling & Yahnke
San Diego,
California
|
+$252K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$213K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$545K | |
| 3 | -$441K | |
| 4 |
Millennium Management
New York
|
-$404K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$396K |